Today's Top SOA Links
From the Wires
New Findings Link Telehealth-Enabled Care Coordination with Reduced Mortality for Patients with Congestive Heart Failure
-- Analysis of data derived from the Medicare Care Management for High-Cost Beneficiaries (CMHCB) Demonstration project shows that care coordination supported by Bosch Healthcare's content-driven remote patient monitoring (the Health Buddy System) result
By: PR Newswire
Nov. 15, 2012 03:00 PM
PALO ALTO, Calif., Nov. 15, 2012 /PRNewswire/ -- Robert Bosch Healthcare, Inc., the market leader in evidence-based telehealth solutions, and a subsidiary of the Bosch Group, today announced new evidence that an integrated telehealth and care management program (the Health Buddy Program) can significantly reduce all-cause mortality in high-cost, high-risk Medicare beneficiaries with heart failure (HF).
In 2010, costs associated with HF were estimated to be $34.4 billion annually (direct and indirect costs).[i] In 2006, Medicare beneficiaries with HF accounted for 37 percent of all Medicare spending and 50 percent of all inpatient hospital costs.[ii] Developing strategies to reduce readmission rates and improve outcomes for patients with HF has become a national health priority.
Retrospective Medicare claims data for HF beneficiaries enrolled in the 2006-2010 Medicare Care Management for High-Cost Beneficiaries (CMHCB) Demonstration in the Pacific Northwest (intervention group) were compared to control HF Medicare beneficiaries. HF was identified by ICD-9 codes and intervention and control beneficiaries were propensity-score matched using logistic regression. The program's effect on all-cause mortality over three years was estimated using Kaplan-Meier survival analysis and Cox proportional hazards models. Data for 623 matched pairs of Medicare HF beneficiaries were analyzed.
The results showed that care management combined with the Health Buddy System was associated with a 25 percent reduction in all-cause mortality risk in beneficiaries with HF, who were offered the program and a 57 percent reduction in mortality risk for those HF beneficiaries who actively participated in the program.
Lead author of the study, Robert L. Page II, PharmD, MSPH, Associate Professor of Clinical Pharmacy at the University of Colorado School of Pharmacy, stated: "Over the past five years, integrated telemedicine programs have become an emerging tool to assist providers in the complex management of patients with heart failure. What sets the Health Buddy Program apart from other devices is that this program engages the patient in all aspects of their care-signs, symptoms, health behaviors, and knowledge of these health behaviors. Our study found a significant reduction in mortality in patients with heart failure with the greatest benefit in those who actually engaged in the program. I believe that the key is motivating the patient to become engaged in their care."
According to Dr. Jasper zu Putlitz, M.D. and president of Robert Bosch Healthcare Systems, Inc.: "These data have once again demonstrated that the Health Buddy System can activate collaboration and inspire engagement among patients and their care team in ways that lead to better clinical outcomes. In this case, it has shown that for heart failure patients, use of the Health Buddy System can extend their lives."
The abstract of the study can be accessed at: http://www.abstractsonline.com/plan/ViewAbstract.aspx?mID=2974&sKey=b70822cd-ea79-4997-91cc-78f0ce4b8c6e&cKey=fdc55578-6d4e-497d-82d5-6720324ef0fe&mKey=%7B14145D5B-F96B-4354-8237-8F0937744BA4%7D
Background on Medicare's CMHCB Demonstration Project
About the Health Buddy System
About Robert Bosch Healthcare
About the Bosch Group
The company was set up in Stuttgart in 1886 by Robert Bosch (1861-1942) as "Workshop for Precision Mechanics and Electrical Engineering." The special ownership structure of Robert Bosch GmbH guarantees the entrepreneurial freedom of the Bosch Group, making it possible for the company to plan over the long term and to undertake significant up-front investments in the safeguarding of its future. Ninety-two percent of the share capital of Robert Bosch GmbH is held by Robert Bosch Stiftung GmbH, a charitable foundation. The majority of voting rights are held by Robert Bosch Industrietreuhand KG, an industrial trust. The entrepreneurial ownership functions are carried out by the trust. The remaining shares are held by the Bosch family and by Robert Bosch GmbH.
[i] Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933–944.
SOURCE Robert Bosch Healthcare, Inc.
Web 2.0 Latest News
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week